papaverine and alpha-synuclein

papaverine has been researched along with alpha-synuclein in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Kang, JL; Kim, DY; Kim, HS; Leem, YH; Park, JE; Park, JS	1

Other Studies

1 other study(ies) available for papaverine and alpha-synuclein

Article	Year
Papaverine inhibits α-synuclein aggregation by modulating neuroinflammation and matrix metalloproteinase-3 expression in the subacute MPTP/P mouse model of Parkinson's disease. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2020, Volume: 130 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; alpha-Synuclein; Animals; Astrocytes; Disease Models, Animal; Dopaminergic Neurons; Male; Matrix Metalloproteinase 3; Mice, Inbred C57BL; Microglia; MPTP Poisoning; Neuroprotective Agents; Neurotoxins; Papaverine; Protein Aggregation, Pathological	2020

Article

Year

Papaverine inhibits α-synuclein aggregation by modulating neuroinflammation and matrix metalloproteinase-3 expression in the subacute MPTP/P mouse model of Parkinson's disease.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2020, Volume: 130

Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; alpha-Synuclein; Animals; Astrocytes; Disease Models, Animal; Dopaminergic Neurons; Male; Matrix Metalloproteinase 3; Mice, Inbred C57BL; Microglia; MPTP Poisoning; Neuroprotective Agents; Neurotoxins; Papaverine; Protein Aggregation, Pathological

2020